#BEGIN_DRUGCARD DB03881

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C12H16N4O3S

# Chemical_IUPAC_Name:
(2R,3S,4S,5S)-3,4-dihydroxy-2-[(methylsulfanyl)methyl]-5-{4-oxopyrrolo[3,2-d]pyrimidin-7-yl}pyrrolidin-1-ium

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
MT-Immucillin-H

# HET_ID:
MTI

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H15N4O3S/c1-20-3-6-10(17)11(18)8(16-6)5-2-13-9-7(5)14-4-15-12(9)19/h2,4,6,8,10-11,16-18H,3H2,1H3,(H,14,15,19)/p+1/t6-,8-,10-,11-/m0/s1

# InChI_Key:
InChIKey=SFMVQWXGRIIFDH-SEZOGAINSA-O

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3881

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
296.345

# Molecular_Weight_Mono:
296.094311088

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1Q1G

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1

# Predicted_LogS:
-2.7

# Predicted_Water_Solubility:
6.22e-01 g/l

# Primary_Accession_No:
DB03881

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936816

# PubChem_Substance_ID:
46506174

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02245

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CSC[C@@H]1[NH2+][C@H]([C@H](O)[C@H]1O)c1cnc2c1N=CNC2=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
(1s)-1-(0-Deazahypoxanthin-9-Yl)-1,4-Dideoxy-1,4-Imino-5-Methylthio-D-Ribitol
5'-Methylthio-Immucillin-H
MT-ImmH

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:43 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
14982926	Shi W, Ting LM, Kicska GA, Lewandowicz A, Tyler PC, Evans GB, Furneaux RH, Kim K, Almo SC, Schramm VL: Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem. 2004 Apr 30;279(18):18103-6. Epub 2004 Feb 23.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
NP

# Drug_Target_1_GenBank_ID_Gene:
X00737

# Drug_Target_1_GenBank_ID_Protein:
35565

# Drug_Target_1_GeneCard_ID:
NP

# Drug_Target_1_Gene_Name:
PNP

# Drug_Target_1_Gene_Sequence:
>870 bp
ATGGAGAACGGATACACCTATGAAGATTATAAGAACACTGCAGAATGGCTTCTGTCTCAT
ACTAAGCACCGACCTCAAGTTGCAATAATCTGTGGTTCTGGATTAGGAGGTCTGACTGAT
AAATTAACTCAGGCCCAGATCTTTGACTACAGTGAAATCCCCAACTTTCCTCGAAGTACA
GTGCCAGGTCATGCTGGCCGACTGGTGTTTGGGTTCCTGAATGGCAGGGCCTGTGTGATG
ATGCAGGGCAGGTTCCACATGTATGAAGGGTACCCACTCTGGAAGGTGACATTCCCAGTG
AGGGTTTTCCACCTTCTGGGTGTGGACACCCTGGTAGTCACCAATGCAGCAGGAGGGCTG
AACCCCAAGTTTGAGGTTGGAGATATCATGCTGATCCGTGACCATATCAACCTACCTGGT
TTCAGTGGTCAGAACCCTCTCAGAGGGCCCAATGATGAAAGGTTTGGAGATCGTTTCCCT
GCCATGTCTGATGCCTACGACCGGACTATGAGGCAGAGGGCTCTCAGTACCTGGAAACAA
ATGGGGGAGCAACGTGAGCTACAGGAAGGCACCTATGTGATGGTGGCAGGCCCCAGCTTT
GAGACTGTGGCAGAATGTCGTGTGCTGCAGAAGCTGGGAGCAGACGCTGTTGGCATGAGT
ACAGTACCAGAAGTTATCGTTGCACGGCACTGTGGACTTCGAGTCTTTGGCTTCTCACTC
ATCACTAACAAGGTCATCATGGATTATGAAAGCCTGGAGAAGGCCAACCATGAAGAAGTC
TTAGCAGCTGGCAAACAAGCTGCACAGAAATTGGAACAGTTTGTCTCCATTCTTATGGCC
AGCATTCCACTCCCTGACAAAGCCAGTTGA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
12928150	Yu L, Kalla K, Guthrie E, Vidrine A, Klimecki WT: Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans. Environ Health Perspect. 2003 Aug;111(11):1421-7.
1384322	Aust MR, Andrews LG, Barrett MJ, Norby-Slycord CJ, Markert ML: Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency. Am J Hum Genet. 1992 Oct;51(4):763-72.
2104852	Ealick SE, Rule SA, Carter DC, Greenhough TJ, Babu YS, Cook WJ, Habash J, Helliwell JR, Stoeckler JD, Parks RE Jr, et al.: Three-dimensional structure of human erythrocytic purine nucleoside phosphorylase at 3.2 A resolution. J Biol Chem. 1990 Jan 25;265(3):1812-20.
3029074	Williams SR, Gekeler V, McIvor RS, Martin DW Jr: A human purine nucleoside phosphorylase deficiency caused by a single base change. J Biol Chem. 1987 Feb 15;262(5):2332-8.
6087295	Williams SR, Goddard JM, Martin DW Jr: Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization. Nucleic Acids Res. 1984 Jul 25;12(14):5779-87.
8931706	Pannicke U, Tuchschmid P, Friedrich W, Bartram CR, Schwarz K: Two novel missense and frameshift mutations in exons 5 and 6 of the purine nucleoside phosphorylase (PNP) gene in a severe combined immunodeficiency (SCID) patient. Hum Genet. 1996 Dec;98(6):706-9.

# Drug_Target_1_HGNC_ID:
HGNC:7892

# Drug_Target_1_HPRD_ID:
01247

# Drug_Target_1_ID:
277

# Drug_Target_1_Locus:
14q13.1

# Drug_Target_1_Molecular_Weight:
32118

# Drug_Target_1_Name:
Purine nucleoside phosphorylase

# Drug_Target_1_Number_of_Residues:
289

# Drug_Target_1_PDB_ID:
1RT9

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00896	Mtap_PNP

# Drug_Target_1_Protein_Sequence:
>Purine nucleoside phosphorylase
MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYGEIPNFPRST
VPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGL
NPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQ
MGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSL
ITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS

# Drug_Target_1_Reaction:
purine nucleoside + phosphate = purine + alpha-D-ribose 1-phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
P00491

# Drug_Target_1_SwissProt_Name:
PNPH_HUMAN

# Drug_Target_1_Synonyms:
EC 2.4.2.1
Inosine phosphorylase
PNP

# Drug_Target_1_Theoretical_pI:
6.95

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AL929352

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
PFE0660c

# Drug_Target_2_Gene_Sequence:
>738 bp
TTAGGCATATTTGGTTGCTAATTTTGCACATGCTCCTAAGGCTATTTTAATCATATTTTC
TAATTGGTGAGGAACTAAATTGTTGTCGAAATCCCCTTCGTCCCATTTGAATGGACATCC
ATCAACAATAAGAATACCACCTGTTTTAACTTTTCTTAAGGTTCCAATAACCATAAGAGT
GGCTAGTTCCATTTCAACAACAGCAGCATTAGCTTTAGAATAATCTTCTAATCTTGAAGG
AATAATTTTATTGGGATAATACATATCTGATGAAACACTGATACCATTAAAAACTGGCAC
ATTCAATTCTTGTGCACATTTATTTAAAGTATCATAAACATCAAAATCACCAACAGCTGG
GAAATCTCCATGAATTAATAAATGAGATACTCTATCTTCCCTAACAGCTGCATTACATAT
ACATATGTCACCTCTTTTTATTAAATCTGGTTGAAGAGATCCACATGAACCTGCACGAAT
AATTACTTTAGCTCCATTTTGACATAATTCTTCAAAACATACAGCACATCCTGCTGAACC
TACACCGTGACTAACACATAAAAATTTCTGACCCTTATAATGACATTCTACACTTTTGTA
TTCTCTGTTGTATGCTAAATCAACATATGAATCACATACCACTTTTATCTTGTCGACTCT
TCCTGGATCTCCTACAACTAAAACAACTGGTGTTATTTGTTCCTTGCTTATTTTTAAATG
GCGTAAAAGATTATCCAT

# Drug_Target_2_General_Function:
Involved in catalytic activity

# Drug_Target_2_General_References:
12368867	Hall N, Pain A, Berriman M, Churcher C, Harris B, Harris D, Mungall K, Bowman S, Atkin R, Baker S, Barron A, Brooks K, Buckee CO, Burrows C, Cherevach I, Chillingworth C, Chillingworth T, Christodoulou Z, Clark L, Clark R, Corton C, Cronin A, Davies R, Davis P, Dear P, Dearden F, Doggett J, Feltwell T, Goble A, Goodhead I, Gwilliam R, Hamlin N, Hance Z, Harper D, Hauser H, Hornsby T, Holroyd S, Horrocks P, Humphray S, Jagels K, James KD, Johnson D, Kerhornou A, Knights A, Konfortov B, Kyes S, Larke N, Lawson D, Lennard N, Line A, Maddison M, McLean J, Mooney P, Moule S, Murphy L, Oliver K, Ormond D, Price C, Quail MA, Rabbinowitsch E, Rajandream MA, Rutter S, Rutherford KM, Sanders M, Simmonds M, Seeger K, Sharp S, Smith R, Squares R, Squares S, Stevens K, Taylor K, Tivey A, Unwin L, Whitehead S, Woodward J, Sulston JE, Craig A, Newbold C, Barrell BG: Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature. 2002 Oct 3;419(6906):527-31.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5421

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
26858

# Drug_Target_2_Name:
Uridine phosphorylase, putative

# Drug_Target_2_Number_of_Residues:
245

# Drug_Target_2_PDB_ID:
1Q1G

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF01048	PNP_UDP_1

# Drug_Target_2_Protein_Sequence:
>Uridine phosphorylase, putative
MDNLLRHLKISKEQITPVVLVVGDPGRVDKIKVVCDSYVDLAYNREYKSVECHYKGQKFL
CVSHGVGSAGCAVCFEELCQNGAKVIIRAGSCGSLQPDLIKRGDICICNAAVREDRVSHL
LIHGDFPAVGDFDVYDTLNKCAQELNVPVFNGISVSSDMYYPNKIIPSRLEDYSKANAAV
VEMELATLMVIGTLRKVKTGGILIVDGCPFKWDEGDFDNNLVPHQLENMIKIALGACAKL
ATKYA

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q8I3X4

# Drug_Target_2_SwissProt_Name:
Q8I3X4_PLAF7

# Drug_Target_2_Synonyms:
EC 2.4.2.3

# Drug_Target_2_Theoretical_pI:
6.49

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03881
